ARCHIVES

FDA Approves Abbott’s HER-2 DNA Probe Kit.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Combination Therapy Improves Survival For HIV+ Patients

February 24, 2006

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

NCI “Leadership Vacuum” Deepened?

December 22, 1994

In Brief: Cowan to Direct Eppley Cancer Center; Nealon Retires From NCI Liaison Office

June 11, 1999

In Brief: HHS Rejects Sole Source Award For Utah Study; Reagan Proclaims April Cancer Control Month

April 3, 1981